Proton Therapy in Supradiaphragmatic Lymphoma: Predicting Treatment-Related Mortality to Help Optimize Patient Selection.
11/11/2019
/
Publications
Published in the Red Journal, this study identified patients who benefit most from PBT in terms of predicted 30-year absolute mortality risks (AMR30) from...
Executive Summary of Clinical and Technical Guidelines for Esophageal Cancer Proton Beam Therapy From the Particle Therapy Co-Operative Group Thoracic and Gastrointestinal Subcommittees.
10/10/2021
/
Publications
/
Dosimetry
Reirradiation
Motion Management
In this guideline document, the dosimetric data and clinical evidence of PBT for esophageal cancer (EC) was summarized and evaluated. The clinical outcome data...
IBA Proton Therapy Conference at ASTRO 2019
15/09/2019
/
Event
/
Immunotherapy
ARC therapy
AMIT MAITY, MD, PhD Executive Vice-Chair Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia "Proton FLASH Radiation...
Randomized Clinical Trial Comparing Proton Beam Radiation Therapy with Transarterial Chemoembolization for Hepatocellular Carcinoma
30/05/2016
/
Publications
/
Clinical Trial
A randomized trial comparing proton therapy with transarterial chemoembolization (TACE) for hepatocellular carcinoma, reported a trend toward improved local...
Factors associated with LT survival in gemcitabine-concurrent PT for non-metastatic LAPC
07/02/2022
/
Publications
123 patients with locally advanced pancreatic cancer (LAPC) treated with gemcitabine-concurrent proton radiotherapy (GPT) were reviewed in this study by the...
Clinical outcomes and toxicities of proton radiotherapy for gastrointestinal neoplasms: a systematic review
30/08/2016
/
Publications
/
Toxicity
A systematic review examined clinical outcomes and toxicities of proton therapy for gastrointestinal neoplasms. The findings include that proton therapy was...
FLASH Radiotherapy Using Single-Energy Proton PBS Transmission Beams for Hypofractionation Liver Cancer: Dose and Dose Rate Quantification.
07/12/2021
/
Publications
/
FLASH Therapy
Hypofractionation
Another study by the group from New York Proton Center (ProBeam) assessed the feasibility of FLASH RT using single-energy transmission PBS plans of 4.5 Gy × 15...
Treating gastrointestinal malignancy with proton therapy
01/10/2016
/
White Paper
/
Toxicity
Dosimetry
Chemotherapy
The improved dosimetry with proton therapy enables greater sparing of normal tissues...
Dose-escalated PT with elective nodal irradiation and concomitant chemotherapy for unresectable, borderline resectable, or medically inoperable pancreatic cancer
13/06/2022
/
Publications
This study by the Jacksonville group reported treatment outcomes of proton therapy for pancreatic cancer. 15 patients received 40.5 GyRBE in 18 fractions to the...
Trends in radiotherapy administration in the management of hepatocellular carcinoma
13/09/2022
/
Publications
/
Survival
Trends in radiotherapy administration in the management of hepatocellular carcinoma: Analysis of a Korean tertiary hospital registry of hepatocellular carcinoma...
Cookies policy
If you continue browsing this website, you agree to the use of cookies in order to provide you with services and offers tailored to your own interests.
Manage your cookie preferences
Respect for your privacy is still a priority for us at IBA.
Functional cookies ensure that the website runs smoothly. They cannot be turned off. By setting your preferences, you can turn the use of these cookies on and off on our website, although these settings will only be valid on the device you are currently using.